Generics 219

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Tazobactam manufacturers

219 products found

Filters

219 products found

tazobactam + ceftriaxone

Vials, injection 125 mg + 1000 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18132

Manufacturer usually replies in 1 days

piperacillin + tazobactam

Injection 2.25 g, 3.375 g, 4.5 g, 40.5 g

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA
Unavailable markets
Australia , Brazil , United Arab Emirates
Registered in
United States
MAs for sale
United States
Manufacturer #17548
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in Europe, North America, and Asia for 100+ years. Main therapeutic areas include gastroenterology, anti-infectious drugs, inflammation and pain, and nutraceuticals. The main dosage forms are injectable, oral, and topical. They are produced in cGMP-compliant manufacture.

Manufacturer usually replies in 11 days

piperacillin + tazobactam

Powder for solution for injection/infusion 2 g/0.25 g, 4 g/0.25 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Denmark , Finland , Iceland , Netherlands , Norway , Sweden
Available for
Distribution only
Comments
Ref: Tazocin®, Zosyn®
Manufacturer #10720

It is one of the oldest pharmaceutical companies specializing in generic mostly for the hospital segment. The key products offered are life-saving medicines, especially in the CNS and cardiovascular therapeutic group. The company follows and complies with the EU GMP requirements.

Manufacturer usually replies in 4 days

piperacillin + tazobactam

Powder for solution for injection 2 g + 250 mg, 4 g + 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, Greece
Unavailable markets
Kosovo
Manufacturer #298

Manufacturer usually replies in 3 days

piperacillin + tazobactam

Vials 2 g + 0.25 g, 4 g + 0.5 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Bolivia , Chile , Colombia , Costa Rica , Dominican Republic , El Salvador , Guatemala , Honduras , Nicaragua , Panama , Paraguay , Peru , Ukraine , Uruguay , Venezuela
Comments
2 g + 0.25 g - DCP ongoing, RMS: NL 4 g + 0.5 g - Dossier availability date: Q3 2024, line extension
Manufacturer #422

A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

piperacillin + tazobactam

Powder for solution for infusion 4 g + 0.5 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Lebanon
Manufacturer #17473
A pharmaceutical manufacturer based in the EU that is active in 40+ countries worldwide selling its products in Europe, the Middle East, LATAM, and Asia for 50+ years. The company has partnerships in the EU for production that comply with GMP standards. Key production lines include pharmaceutical products, nutraceuticals, medical devices, and cosmetics. Therapy areas include anti-infectives, anti-inflammatory and dermatological. The company has its R&D and regulatory affairs department for CTD dossier and marketing authorization management.

Manufacturer usually replies in 5 days

piperacillin + tazobactam

Powder and solvent for solution for injection 2 g + 0.25 g - 4 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq
Manufacturer #17473
A pharmaceutical manufacturer based in the EU that is active in 40+ countries worldwide selling its products in Europe, the Middle East, LATAM, and Asia for 50+ years. The company has partnerships in the EU for production that comply with GMP standards. Key production lines include pharmaceutical products, nutraceuticals, medical devices, and cosmetics. Therapy areas include anti-infectives, anti-inflammatory and dermatological. The company has its R&D and regulatory affairs department for CTD dossier and marketing authorization management.

Manufacturer usually replies in 5 days

piperacillin + tazobactam

Powder and solvent for solution for infusion 2 g + 0.25 g/4 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17360
It is a privately held company that was founded in the 1940s in Italy. Several patents under the company's name have been obtained in Europe and the United States. High standards are ensured by the use of advanced computerized systems for the production of all pharmaceutical dosage forms, including tablets, capsules, syrups, sterile ampoules, and powder for injectable vials.

Manufacturer usually replies in 8 days

piperacillin + tazobactam

Solution for infusion 2,25g - 20ml, 3,375g - 20ml, 4,5g - 50ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #651

Manufacturer usually replies in 6 days

piperacillin + tazobactam

Vials, injection 2 g + 250 mg, 4 g + 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Algeria , Angola , Bahrain , Bulgaria , Cameroon , Colombia , Egypt , Ghana , Iran , Iraq , Israel , Jordan , Lebanon , Libya , Lithuania , Morocco , Nigeria , Oman , Qatar , Saudi Arabia , Senegal , South Africa , Sudan , Syria , Tunisia , United Arab Emirates , Vietnam , Yemen
Manufacturer #686
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, CIS, North America, LATAM, Africa, and Asia for 30+ years. The key production line is Rx. Main therapeutic areas include antibiotics, neurology, and cardiovascular. The main dosage form is injectable. The company's production lines are GMP-compliant. The company possesses different production lines in the EU.

Manufacturer usually replies in 5 days

piperacillin + tazobactam

Injection 2.25 g , 4.5 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
United Arab Emirates
Manufacturer #17548
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in Europe, North America, and Asia for 100+ years. Main therapeutic areas include gastroenterology, anti-infectious drugs, inflammation and pain, and nutraceuticals. The main dosage forms are injectable, oral, and topical. They are produced in cGMP-compliant manufacture.

Manufacturer usually replies in 11 days

piperacillin + tazobactam

Injection 3.375 g , 40.5 g

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17548
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in Europe, North America, and Asia for 100+ years. Main therapeutic areas include gastroenterology, anti-infectious drugs, inflammation and pain, and nutraceuticals. The main dosage forms are injectable, oral, and topical. They are produced in cGMP-compliant manufacture.

Manufacturer usually replies in 11 days

piperacillin + tazobactam

Powder for solution for infusion 2.5 g, 2.5 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP
Unavailable markets
Serbia , Vietnam
Comments
Reference product: Tazocin, Pfizer
Manufacturer #3436

A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products in Europe, the Middle East, LATAM, North America, Africa, and Asia for 60+ years. Key production lines are Rx, OTC, and nutraceuticals. The company's production lines are EU GMP-compliant. Main therapeutic areas include the cardiovascular system, CNS, and dermatology. Main dosage forms include solid, topical, and suppositories.

Manufacturer usually replies in 19 days

piperacillin + tazobactam

Powder for solution for infusion 2 g/250 mg, 3 g/375 mg, 4 g/500 mg, 12 g/1.5 g, 36 g/4.5 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Manufacturer #354

piperacillin + tazobactam

Injection 4.5 g - 30 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
South Africa
Manufacturer #638

Manufacturer usually replies in 8 days

ceftriaxone + tazobactam

Injection 1.125 g, 2.25 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 6 days

cefepime + tazobactam

Solution for injection 1 g + 125 mg, 500 mg + 62.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 6 days

ceftriaxone + tazobactam

Powder for solution for injection 1 g + 0.125 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
PICS
Manufacturer #21567

Manufacturer usually replies in 2 days

cefepime + tazobactam

Powder for solution for injection 1 g + 125 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
PICS
Manufacturer #21567

Manufacturer usually replies in 2 days

ceftazidime + tazobactam

Powder for solution for injection 125 mg, 250 mg, 500 mg, 1000 mg, 2000 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21177

Manufacturer usually replies in 12 days

Want to view all 219 products? Create your free account today!

TAZOBACTAM

Tazobactam is a penicillin that is heavily modified and a sulfone. It inhibits the action of bacterial β-lactamases, especially those belonging to the SHV-1 and TEM groups. Simply put, it is an ingredient that can be added to certain antibiotics to make them less vulnerable to bacteria's antimicrobial resistance. Tazobactam is commonly used as in its sodium salt, tazobactam sodium form. Tazobactam is combined with the extended-spectrum β-lactam antibiotic piperacillin in the drug piperacillin/tazobactam, used in infections due to Pseudomonas aeruginosa. Tazobactam expands the spectrum of activity by making it effective against organisms that express β-lactamase and would normally degrade piperacillin. Piperacillin with tazobactam is penicillin antibiotic used to treat different infections caused by bacteria, like stomach, skin, pneumonia, and severe vaginal infections. Tazobactam is sold under the brand name Zerbaxa, Zosyn amongst others. Taiho Pharmaceutical Company filed some of the first patent related to making this medicine in 1982 and came into medical use in 1992. Since then the patents have expired, many other companies have made their formulations of this medicine.

Forms and dose:

Piperacillin is sold as Piperacillin/Tazobactam 4 g/0.5 g Powder for Solution for Infusion, where 1 vial has 4 g piperacillin as sodium salt and 0.5 g tazobactam as the sodium salt. The usual recommended adult dose is 4 g piperacillin / 0.5 g tazobactam administered every eight hours. While treating nosocomial pneumonia and bacterial infections in neutropenic patients, the usual recommended adult dose is 4 g piperacillin / 0.5 g tazobactam administered every six hours. For children under 2 years of age, the dose is 80 mg Piperacillin / 10 mg Tazobactam per kilo of body weight given every six hours for treating Neutropenic children with fever suspected to be due to bacterial infections. For treating Complicated intra-abdominal infections, the recommended dose is 100 mg Piperacillin / 12.5 mg Tazobactam per kilo of body weight given every eight hours.

The price of Tazobactam

In the USA, depending on the pharmacy and brands, for a supply of 10 powder for injection, the consumers have to pay between $69.30 and $138.60. the same supply of 10 powder for injection will cost around USD60 in India.

How does it work?

Tazobactam works by inhibiting the action of bacterial beta-lactamase producing organisms. These are normally resistant to beta-lactam antibiotics. Tazobactam augments the efficacy of antibiotic that would otherwise not be effective in treating certain infections.

Finding Tazobactam Manufacturers and Suppliers

The best way to find and gain access to Tazobactam manufacturers and Tazobactam suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Tazobactam can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Tazobactam to work with. You can fine-tune your search results using various filters too, letting you search for Tazobactam from specific countries.